-
LGMD2E Children Show Improvements in Gene Therapy in Trial
Children with LGMD2E treated with the investigational gene therapy MYO-101 in a trial showed marked production of beta-sarcoglycan, Sarepta announced. Click here to learn more.
What are your thoughts on this news?
Sorry, there were no replies found.
Log in to reply.